510(k) device
Tci (Tinnitus Control Instrument)
Siemens Hearing Instruments, Inc. · Masker, Tinnitus (KLW, Class II) · First FDA decision Apr 26, 2001, newest Apr 26, 2001Tinnitus
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
66
Naming "Tci"
MAUDE reports
11
Brand "Tci", since 2015
PubMed studies
3,792
Mentioning "Tci"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Tci (Tinnitus Control Instrument)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K003559 · Decided Apr 26, 2001 · 160 days after receipt
Device type: Masker, Tinnitus (KLW) · Otolaryngology (ENT)
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Tci", any status and sponsor, newest update first.
Hospital Provincial de RosarioAcademic, hospital or other
NCT07571473 · 30 participants (planned) · Start Jan 8, 2025 · Primary completion Mar 31, 2027
Device: CoreSys Monitor · For: Surgical Stress Response; Inflammation; Anesthesia and 1 more
Sites: Rosario, Argentina
- Comparison of Target-Controlled and Manual Total Intravenous Anesthesia in Supratentorial SurgeryCompleted
Istanbul University - CerrahpasaAcademic, hospital or other
NCT07357480 · 63 participants · Start Jan 14, 2026 · Primary completion Jun 7, 2026
Device: Target Controlled Infusion; Total Intravenous Anesthesia(TIVA) · For: Postoperative Delirium (POD); Postoperative Pain; PONV and 2 more
Sites: Istanbul, Turkey (Türkiye) · 2 sites in all
- TCI Versus Manual TIVA for Sedation During Prone Kyphoplasty: Effects on Respiration, Recovery, and EEGNot yet recruiting
Marmara University Pendik Training and Research HospitalAcademic, hospital or other
NCT07745348 · 50 participants (planned) · Start Jul 10, 2026 · Primary completion Jul 10, 2027
Device: non invasive ETCO2 monitoring · For: Kyphoplasty; Prone Position; Target Controlled Infusion of Propofol and 1 more
Sites: Istanbul, Turkey (Türkiye)
63 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Tci", and for the whole product code for context.
This brand
11 reports: 10 malfunction, 0 injury, 1 death
Whole product code KLW
4 reports: 1 malfunction, 3 injury, 0 death
Newest reports for this brand
- BD TIVA/TCI SET 3-WMalfunction
SISTEMAS MEDICOS ALARIS S.A DE C.V.
9616066-2025-04182 · Received Jan 14, 2026 · Event dated Dec 19, 2025
Device type: Set, Administration, Intravascular (FPA)
Device problem as coded: Material Split, Cut or Torn
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- BD TIVA/TCI SET 3-WMalfunction
SISTEMAS MEDICOS ALARIS S.A DE C.V.
9616066-2025-04055 · Received Jan 2, 2026 · Event dated Nov 25, 2025
Device type: Set, Administration, Intravascular (FPA)
Device problem as coded: Complete Blockage
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- BD TIVA/TCI EXTENSION SET 3-WAY 2SSMalfunction
SISTEMAS MEDICOS ALARIS S.A DE C.V.
9616066-2025-03828 · Received Dec 18, 2025 · Event dated Nov 24, 2025
Device type: Set, Administration, Intravascular (FPA)
Device problem as coded: Material Separation
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Tci"[tiab]. The summary above synthesizes these.
- Dissipation + Utilization = Self-Organization.
Crecraft H · Entropy (Basel) · 2023
- [Target-controlled intravenous anesthesia].
Billard V, Cazalaà JB, Servin F, et al. · Ann Fr Anesth Reanim · 1997English Abstract, Review
- TDM is dead. Long live TCI!
Holford N, Ma G, Metz D · Br J Clin Pharmacol · 2022Review
- Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients.
Spyridonidis A, Labopin M, Savani BN, et al. · Bone Marrow Transplant · 2020
- Target controlled infusion: TCI.
Guarracino F, Lapolla F, Cariello C, et al. · Minerva Anestesiol · 2005Review
- The History of Target-Controlled Infusion.
Struys MM, De Smet T, Glen JI, et al. · Anesth Analg · 2016Historical Article, Research Support, Non-U.S. Gov't
- Steady-state trumps accuracy: target-controlled infusion as a gain switch.
Egan TD, Minto CF, Schnider TW · Br J Anaesth · 2024Editorial
- Topological constant-intensity waves.
Ossi N, Chandramouli S, Musslimani ZH, et al. · Opt Lett · 2022
- Altermagnetism Induced Surface Chern Insulator.
Jiang X, Akbar Ghorashi SA, Lu D, et al. · Nano Lett · 2026
- Glycosylation of Trypanosoma cruzi TcI antigen reveals recognition by chagasic sera.
Murphy N, Rooney B, Bhattacharyya T, et al. · Sci Rep · 2020Research Support, Non-U.S. Gov't
- The Safety of Target-Controlled Infusions.
Schnider TW, Minto CF, Struys MM, et al. · Anesth Analg · 2016Review
- Target-Controlled Infusion: A Mature Technology.
Absalom AR, Glen JI, Zwart GJ, et al. · Anesth Analg · 2016Review
Other devices of this type
Also filed under product code KLW.
- Tinnitus Sound Generator ModuleGN Hearing A/S · 510(k) 2020
- Tinnitus Sound Generator ModuleGn Resound A/S · 510(k) 2015
- Multiflex Tinnitus TechnologyStarkey Laboratories, Inc. · 510(k) 2020
- SoundCure Serenade Tinnitus Treatment SystemSoundcure, Inc. · 510(k) 2015
- Levo Gen 2 Tinnitus Therapy SystemLevo Medical Corporation · 510(k) 2026
- Tinnitus TherapySivantos GmbH · 510(k) 2026
- Peace N Quiet (0.7.0)Pnq Health · 510(k) 2024
- Tinearity G1 (6103)Duearity AB · 510(k) 2023
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.